BioRhex was built to operate differently.

Every compound is synthesized in a GMP-compliant, US-based facility. Every batch is tested by independent third-party laboratories using HPLC and mass spectrometry verification, with sterility testing conducted to research-grade standards.

Every order ships with a Certificate of Analysis — not as a marketing feature, but as a baseline requirement.

≥99% purity is not a claim. It is a documented, verifiable threshold we hold every batch to before it ships.
This is not a higher bar than other suppliers. This is the bar that should have existed from the start.

MOST REQUESTED

The compounds researchers reorder. Same ≥99% purity threshold. Same batch-specific COA. US-manufactured, HPLC and mass spectrometry verified.

What Every BioRhex Compound Goes Through

No compound ships without meeting every requirement below.

USA Manufacturing

Synthesized in a domestic, GMP-compliant facility. No offshore sourcing. No unverifiable supply chain.

GMP-Compliant Production

Every compound is produced under Good Manufacturing Practice standards, ensuring consistency across every batch.

HPLC Purity Verification

High-performance liquid chromatography testing confirms compound identity and purity against established reference standards.

Mass Spectrometry Confirmation

Mass spectrometry analysis verifies molecular weight and compound identity, providing a second independent layer of purity confirmation.

Sterility Testing

Each batch undergoes sterility testing to research-grade standards before release.

≥99% Purity Threshold

BioRhex maintains a minimum purity threshold of ≥99% across all compounds. Batches that do not meet this standard are not released.